Genotype-phenotype association and variant characterization in Diamond-Blackfan anemia caused by pathogenic variants in RPL35A

Matthew D Gianferante, Marcin W Wlodarski, Evangelia Atsidaftos, Lydie Da Costa, Polyxeni Delaporta, Jason E Farrar, Frederick D Goldman, Maryam Hussain, Antonis Kattamis, Thierry Leblanc, Jeffrey M Lipton, Charlotte M Niemeyer, Dagmar Pospisilova, Paola Quarello, Ugo Ramenghi, Vijay G Sankaran, Adrianna Vlachos, Jana Volejnikova, Blanche P Alter, Sharon A Savage, Neelam Giri, Matthew D Gianferante, Marcin W Wlodarski, Evangelia Atsidaftos, Lydie Da Costa, Polyxeni Delaporta, Jason E Farrar, Frederick D Goldman, Maryam Hussain, Antonis Kattamis, Thierry Leblanc, Jeffrey M Lipton, Charlotte M Niemeyer, Dagmar Pospisilova, Paola Quarello, Ugo Ramenghi, Vijay G Sankaran, Adrianna Vlachos, Jana Volejnikova, Blanche P Alter, Sharon A Savage, Neelam Giri

Abstract

Diamond Blackfan anemia (DBA) is predominantly an autosomal dominant inherited red cell aplasia primarily caused by pathogenic germline variants in ribosomal protein genes. DBA due to pathogenic RPL35A variants has been associated with large 3q29 deletions and phenotypes not common in DBA. We conducted a multi-institutional genotype-phenotype study of 45 patients with DBA associated with pathogenic RPL35A germline variants and curated the variant data on 21 additional cases from the literature. Genotype-phenotype analyses were conducted comparing patients with large deletions versus all other pathogenic variants in RPL35A. Twenty-two of the 45 cases had large deletions in RPL35A. After adjusting for multiple tests, a statistically significant association was observed between patients with a large deletion and steroid-resistant anemia, neutropenia, craniofacial abnormalities, chronic gastrointestinal problems, and intellectual disabilities (p<0.01) compared with all other pathogenic variants. Non-large deletion pathogenic variants were spread across RPL35A with no apparent hot spot and 56% of the individual family variants were observed more than once. In this, the largest known study of DBA patients with pathogenic RPL35A variants, we determined that patients with large deletions have a more severe phenotype that is clinically different from those with non-large deletion variants. Genes of interest also deleted in the 3q29 region that could be associated with some of these phenotypic features include LMLN and IQCG. Management of DBA due to large RPL35A deletions may be challenging due to complex problems and require comprehensive assessments by multiple specialists including immunologic, gastrointestinal, and developmental evaluations to provide optimal multidisciplinary care.

Figures

Figure 1.
Figure 1.
Study population and types of RPL35A variants in patients with Diamond-Blackfan anemia (DBA). NCI: National Cancer Institute Inherited Bone Marrow Failure Study; DBAR: DBA registry; HGMD: Human Gene Mutation Database; Alabama Children’s: Arkansas Children’s Hospital; Boston Children’s: Boston Children’s Hospital; UTR: untranslated regions; ClinVar: ClinVar public data archive.
Figure 2.
Figure 2.
Distribution of RPL35A pathogenic variants reported in patients with Diamond-Blackfan anemia (DBA). All pathogenic single nucleotide and small indel variants are represented once per family. cDNA position based on transcript NM_000996.3. Numbers and letters indicate amino acids. Dotted lines indicate exons. Gray circles: literature, HGMD, and ClinVar cases. Black circles: collaborator cases. Cluster, defined as >5 unrelated cases by family in one area, is located between codon 28 to 33 (*). The numbers within the circles indicate the number of unique families with that specific pathogenic variant.
Figure 3.
Figure 3.
Cases of RPL35A large deletions ordered by size in megabases (mB). Each horizontal bar represents the starting and stopping genomic co-ordinates of a RPL35A large deletion case. For literature cases without a case identification (ID) in article, the PubMed ID (PMID) was used as case ID (Online Supplementary Table S3). Thin black vertical lines indicate genomic starting and stopping co-ordinates of 3q29 deletion syndrome; thick black vertical line is the estimated location of RPL35A. See Online Supplementary Table S5 for exact genes deleted per case.

References

    1. Vlachos A, Ball S, Dahl N, et al. . Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol. 2008;142(6):859-876.
    1. Campagnoli MF, Garelli E, Quarello P, et al. . Molecular basis of Diamond-Blackfan anemia: new findings from the Italian registry and a review of the literature. Haematologica. 2004;89(4):480-489.
    1. Ball SE, McGuckin CP, Jenkins G, et al. . Diamond-Blackfan anaemia in the U.K.: analysis of 80 cases from a 20-year birth cohort. Br J Haematol. 1996;94(4):645-653.
    1. Willig TN, Niemeyer CM, Leblanc T, et al. . Identification of new prognosis factors from the clinical and epidemiologic analysis of a registry of 229 Diamond-Blackfan anemia patients. DBA group of Societe d'Hematologie et d'Immunologie Pediatrique (SHIP), Gesellshaft fur Padiatrische Onkologie und Hamatologie (GPOH), and the European Society for Pediatric Hematology and Immunology (ESPHI). Pediatr Res. 1999;46(5):553-561.
    1. Willig TN, Ball SE, Tchernia G. Current concepts and issues in Diamond-Blackfan anemia. Curr Opin Hematol. 1998;5(2):109-115.
    1. Diamond LK, Wang WC, Alter BP. Congenital hypoplastic anemia. Adv Pediatr. 1976;22:349-378.
    1. Vlachos A, Rosenberg PS, Atsidaftos E, et al. . Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Blood. 2012;119(16):3815-3819.
    1. Vlachos A, Rosenberg PS, Atsidaftos E, et al. . Increased risk of colon cancer and osteogenic sarcoma in Diamond-Blackfan anemia. Blood. 2018;132(20):2205-2208.
    1. Narla A, Vlachos A, Nathan DG. Diamond Blackfan anemia treatment: past, present, and future. Semin Hematol. 2011;48(2):117-123.
    1. Ulirsch JC, Verboon JM, Kazerounian S, et al. . The genetic landscape of Diamond- Blackfan anemia. Am J Hum Genet. 2018;103(6):930-947.
    1. Khajuria RK, Munschauer M, Ulirsch JC, et al. . Ribosome levels selectively regulate translation and lineage commitment in human hematopoiesis. Cell. 2018;173(1):90-103.e119.
    1. Arbiv OA, Cuvelier G, Klaassen RJ, et al. . Molecular analysis and genotype-phenotype correlation of Diamond-Blackfan anemia. Clin Genet. 2018;93(2):320-328.
    1. Kuramitsu M, Sato-Otsubo A, Morio T, et al. . Extensive gene deletions in Japanese patients with Diamond-Blackfan anemia. Blood. 2012;119(10):2376-2384.
    1. Farrar JE, Nater M, Caywood E, et al. . Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia. Blood. 2008;112(5):1582-1592.
    1. Alkhunaizi E, Schrewe B, Alizadehfar R, et al. . Novel 3q27.2-qter deletion in a patient with Diamond-Blackfan anemia and immunodeficiency: case report and review of literature. Am J Med Genet A. 2017; 173(6):1514-1520.
    1. Smetanina NS, Mersiyanova IV, Kurnikova MA, et al. . Clinical and genomic heterogeneity of Diamond Blackfan anemia in the Russian Federation. Pediatr Blood Cancer. 2015;62(9):1597-1600.
    1. Waespe N, Dhanraj S, Wahala M, et al. . The clinical impact of copy number variants in inherited bone marrow failure syndromes. NPJ Genom Med. 2017;2:18.
    1. Quarello P, Garelli E, Brusco A, et al. . High frequency of ribosomal protein gene deletions in Italian Diamond-Blackfan anemia patients detected by multiplex ligationdependent probe amplification assay. Haematologica. 2012;97(12):1813-1817.
    1. Wang R, Yoshida K, Toki T, et al. . Loss of function mutations in RPL27 and RPS27 identified by whole-exome sequencing in Diamond-Blackfan anaemia. Br J Haematol. 2015;168(6):854-864.
    1. Wan Y, Chen X, An W, et al. . Clinical features, mutations and treatment of 104 patients of Diamond-Blackfan anemia in China: a single-center retrospective study. Int J Hematol. 2016;104(4):430-439.
    1. Glassford MR, Rosenfeld JA, Freedman AA, et al. . Novel features of 3q29 deletion syndrome: results from the 3q29 registry. Am J Med Genet A. 2016;170a(4):999-1006.
    1. Murphy MM, Lindsey Burrell T, Cubells JF, et al. . Study protocol for The Emory 3q29 Project: evaluation of neurodevelopmental, psychiatric, and medical symptoms in 3q29 deletion syndrome. BMC Psychiatry. 2018;18(1):183.
    1. Digilio MC, Bernardini L, Mingarelli R, et al. . 3q29 microdeletion: a mental retardation disorder unassociated with a recognizable phenotype in two mother-daughter pairs. Am J Med Genet A. 2009;149a(8):1777-1781.
    1. Willatt L, Cox J, Barber J, et al. . 3q29 microdeletion syndrome: clinical and molecular characterization of a new syndrome. Am J Hum Genet. 2005;77(1):154-160.
    1. Alter BP, Giri N, Savage SA, et al. . Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up. Haematologica. 2018;103(1):30-39.
    1. Lipton JM, Atsidaftos E, Zyskind I, et al. . Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry. Pediatr Blood Cancer. 2006;46(5):558-564.
    1. Landrum MJ, Lee JM, Benson M, et al. . ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46(D1):D1062-D1067.
    1. Stenson PD, Mort M, Ball EV, et al. . The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet. 2014;133(1):1-9.
    1. ClinGen. Clinical laboratories meeting minimum requirements for data sharing to support quality assurance. accessed 22 Feb 2019.
    1. Da Costa L, Narla A, Mohandas N. An update on the pathogenesis and diagnosis of Diamond-Blackfan anemia. 2018;7:F1000 Faculty Rev-1350..
    1. Bessler M, Mason P, Link D, et al. . Nathan and Oski's Hematology of Infancy and Childhood E-Book: Expert Consult: Online and Print. Orkin SH, ed. Inherited Bone Marrow Failure Syndromes. 7th ed: Elsevier Health Sciences; 2009:351-360.
    1. Karczewski KJ, Francioli LC, Tiao G, et al. . Variation across 141,456 human exomes and genomes reveals the spectrum of loss-offunction intolerance across human proteincoding genes. bioRxiv. 2019:531210.
    1. Rentzsch P, Witten D, Cooper GM, et al. . CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 2019;47(D1):D886-D894.
    1. Ioannidis NM, Rothstein JH, Pejaver V, et al. . REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet. 2016;99(4):877-885.
    1. Cingolani P, Platts A, Wang LL, et al. . A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly. 2012;6(2):80-92.
    1. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164.
    1. Zhou X, Edmonson MN, Wilkinson MR, et al. . Exploring genomic alteration in pediatric cancer using ProteinPaint. Nat Genet. 2016;48(1):4-6.
    1. Karolchik D, Hinrichs AS, Furey TS, et al. . The UCSC Table Browser data retrieval tool. Nucleic Acids Res. 2004;32(Database issue):D493-D496.
    1. StataCorp. Stata Statistical Software: Release 15. College Station, TX: StataCorp LLC. 2017.
    1. Mirabello L, Khincha PP, Ellis SR, et al. . Novel and known ribosomal causes of Diamond- Blackfan anaemia identified through comprehensive genomic characterisation. J Med Genet. 2017;54(6):417-425.
    1. Delaporta P, Sofocleous C, Stiakaki E, et al. . Clinical phenotype and genetic analysis of RPS19, RPL5, and RPL11 genes in Greek patients with Diamond Blackfan Anemia. Pediatr Blood Cancer. 2014;61(12):2249-2255.
    1. Quarello P, Garelli E, Carando A, et al. . Ribosomal RNA analysis in the diagnosis of Diamond-Blackfan anaemia. Br J Haematol. 2016;172(5):782-785.
    1. Farrar JE, Dahl N. Untangling the phenotypic heterogeneity of Diamond Blackfan anemia. Semin Hematol. 2011;48(2):124-135.
    1. Li F, Lisi EC, Wohler ES, et al. . 3q29 interstitial microdeletion syndrome: an inherited case associated with cardiac defect and normal cognition. Eur J Med Genet. 2009; 52(5):349-352.
    1. Pollazzon M, Grosso S, Papa FT, et al. . A 9.3 Mb microdeletion of 3q27.3q29 associated with psychomotor and growth delay, tricuspid valve dysplasia and bifid thumb. Eur J Med Genet. 2009;52(2-3):131-133.
    1. Quintero-Rivera F, Sharifi-Hannauer P, Martinez-Agosto JA. Autistic and psychiatric findings associated with the 3q29 microdeletion syndrome: case report and review. Am J Med Genet A. 2010; 152a(10):2459-2467.
    1. McHugh B, Krause SA, Yu B, et al. . Invadolysin: a novel, conserved metalloprotease links mitotic structural rearrangements with cell migration. J Cell Biol. 2004; 167(4):673-686.
    1. Cobbe N, Marshall KM, Gururaja Rao S, et al. . The conserved metalloprotease invadolysin localizes to the surface of lipid droplets. J Cell Sci. 2009;122(Pt 18):3414-3423.
    1. Chen LT, Liang WX, Chen S, et al. . Functional and molecular features of the calmodulin-interacting protein IQCG required for haematopoiesis in zebrafish. Nat Commun. 2014;5:3811.
    1. Pan M, Zhang Q, Liu P, et al. . Inhibition of the nuclear export of p65 and IQCG in leukemogenesis by NUP98-IQCG. Front Med. 2016;10(4):410-419.
    1. Pan Q, Zhu YJ, Gu BW, et al. . A new fusion gene NUP98-IQCG identified in an acute Tlymphoid/ myeloid leukemia with a t(3;11)(q29q13;p15)del(3)(q29) translocation. Oncogene. 2008;27(24):3414-3423.

Source: PubMed

3
Se inscrever